Skip to main content
. 2014 May 1;306(12):G1108–G1116. doi: 10.1152/ajpgi.00072.2014

Table 1.

Results of ANOVA statistical tests for studies 1, 2 and 3 showing F-statistics and significant differences (P < 0.05) for differences across conditions

Ghrelin Nadir
D-AUC3h
D-AUCtotal
Study 1: Infusions of glucose, 3-O-MG, and lactulose
Dose effects
    Glucose F(3,27) = 12 P < 0.001 F(3,27) = 18 P < 0.001 F(3,27) = 5.8 P = 0.003
    3-O-MG F(3,25) = 3.5 P = 0.03 F(3,25) = 5.8 P = 0.004 NS
    Lactulose F(3,30) = 3.4 P = 0.03 F(3,30) = 3.4 P < 0.03 NS
Substance effects
    Isotonic NS NS NS
    2.5-fold hypertonic F(2,18) = 4.5 P = 0.02 NS NS
    5-fold hypertonic F(3,23) = 6.3 P = 0.003 F(3,23) = 20 P < 0.001 F(3,23) = 3.5 P = 0.03
Study 2: Infusions of isotonic saline, 5-fold hypertonic saline, and 5-fold hypertonic saline + lidocaine
Between-condition effect F(2,20) = 7.6 P = 0.003 F(2,20) = 4.3 P = 0.03 NS
Study 3: Infusions of Intralipid, isocaloric glucose, and iso-osmotic Intralipid + lactulose
Between-condition effect F(2,13) = 10 P = 0.002 F(2,13) = 34 P < 0.001 F(2,13) = 6.6 P = 0.01

Data are shown for 3 parameters of plasma ghrelin responses to infusions: ghrelin nadir, i.e., ghrelin levels at maximum suppression and D-AUC3 h and D-AUCtot, i.e., the decremental area under the ghrelin curve for the 3-h and 5-h postinfusion time intervals, respectively. Post hoc test results with Bonferroni correction are described in the main text. Results for a fourth parameter, time to ghrelin nadir (TGN) were all nonsignificant and were omitted from the table. 3-O-MG, 3-O-methylglucose. NS, nonsignificance (P > 0.05).